Vimarsana
Biggest News Aggregation in the World

Page 13 - Truth Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Truth Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Truth Group Today - Breaking & Trending Today

OrthoPediatrics Corp. Introduces Orthex in Australia - Vimarsana News

OrthoPediatrics Corp. Introduces Orthex in Australia

Press release content from Globe Newswire. The AP news staff was not involved in its creation. OrthoPediatrics Corp. Introduces Orthex in Australia OrthoPediatrics Corp.January 22, 2021 GMT WARSAW, Ind., Jan. 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand. Within the past 12 months we have launched the Pediatric Nailing Platform (PNP), Response 4.5/5.0 Spine System and most recently, the Orthex system...

Source: apnews.com
ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering - Vimarsana News

ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering

ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering SAN CLEMENTE, CA / ACCESSWIRE / January 20, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, announced today that it has entered into a definitive merger agreement with Obalon Therapeutics, Inc., which is listed on the NASDAQ Capital Market, a company focused on developing and commercializing novel technologies for weight loss, under which ReShape and Obalon will combine in an all-stock transaction. Under the terms of the merger agreement that has been...

Number of Shares and Voting Rights of ADOCIA as of December 31, 2020 - Vimarsana News

Number of Shares and Voting Rights of ADOCIA as of December 31, 2020

Number of Shares and Voting Rights of ADOCIA as of December 31, 2020 Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers, or "AMF") charter ADOCIA SA, a French société anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon, (Paris:ADOC) (Euronext Paris: FR0011184241 ADOC) a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, releases its total number of outstanding shares as well ...

Adocia Announces Half Year Report on Adocia's Liquidity Agreement With Kepler Capital Markets - Vimarsana News

Adocia Announces Half Year Report on Adocia's Liquidity Agreement With Kepler Capital Markets

Adocia Announces Half Year Report on Adocia's Liquidity Agreement With Kepler Capital Markets Regulatory News: Under the liquidity agreement entrusted by Adocia (Paris:ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on - Number of executions on sell side on semester: 355 - Traded volume on buy side on semester: 45,143 shares for 353,656.52 - Traded volume on sell side on semester: 47,151 shares for 374,968.20 As a reminder: on June 30, 2020 on the liquidity account: 32,541 shares 15,026 shares - 300,000.00 The liquidity agreement complies with AM...

Evoke Pharma Announces Pricing of Public Offering of Common Stock - Vimarsana News

Evoke Pharma Announces Pricing of Public Offering of Common Stock

Evoke Pharma Announces Pricing of Public Offering of Common Stock January 13, 2021 20:03 ET | Source: Evoke Pharma, Inc. Evoke Pharma, Inc. Solana Beach, California, UNITED STATES SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that it has priced an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $2.50 per share. Gross proceeds, before ...